GlycoMimetics
GLYC
$1.71
Share price
-7.82%
Change (1 day)
24.82%
Change (1 year)
Categories
Market capitalization of GlycoMimetics (GLYC)
Market cap: $0.11 Billion
As of April 2024 GlycoMimetics has a market cap of $0.11 Billion. This makes GlycoMimetics the world's 7332th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of GlycoMimetics from 2014 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $0.11 B | -27.48% |
| 2023 | $0.15 B | -4.33% |
| 2022 | $0.15 B | 113.2% |
| 2021 | $74.5 M | -59.58% |
| 2020 | $0.18 B | -19.85% |
| 2019 | $0.22 B | -43.74% |
| 2018 | $0.40 B | -29.1% |
| 2017 | $0.57 B | 309.77% |
| 2016 | $0.14 B | 29.12% |
| 2015 | $0.10 B | -20.09% |
| 2014 | $0.13 B |
End of Day market cap according to different sources
On Apr 25th, 2024 the market cap of GlycoMimetics was reported to be:
$0.11 Billion
$0.11 Billion
$0.11 Billion
$0.11 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $353.80 B | 320,926.53% | 🇺🇸 USA |
 Pfizer PFE | $143.03 B | 129,684.52% | 🇺🇸 USA |
 Sanofi SNY | $123.22 B | 111,708.88% | 🇫🇷 France |
 Palatin Technologies PTN | $27.75 M | -74.82% | 🇺🇸 USA |
 bluebird bio
BLUE | $0.17 B | 59.58% | 🇺🇸 USA |